As one of the most important intracellular signaling pathways, the Phosphoinositide-3-Kinase (PI3K)/mammalian target of rapamycin (mTOR) pathway is frequently altered in human cancers [4, 5], including HCC [6]. Here, MTOR is linked to cancer.